FI70888C - Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara n-(fenoxialkyl)imidazolderivat - Google Patents

Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara n-(fenoxialkyl)imidazolderivat Download PDF

Info

Publication number
FI70888C
FI70888C FI793868A FI793868A FI70888C FI 70888 C FI70888 C FI 70888C FI 793868 A FI793868 A FI 793868A FI 793868 A FI793868 A FI 793868A FI 70888 C FI70888 C FI 70888C
Authority
FI
Finland
Prior art keywords
alkyl
compound
imidazole
give
ethyl
Prior art date
Application number
FI793868A
Other languages
English (en)
Finnish (fi)
Other versions
FI793868A (fi
FI70888B (fi
Inventor
Peter Edward Cross
Roger Peter Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI70888(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of FI793868A publication Critical patent/FI793868A/fi
Application granted granted Critical
Publication of FI70888B publication Critical patent/FI70888B/fi
Publication of FI70888C publication Critical patent/FI70888C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI793868A 1978-12-13 1979-12-11 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara n-(fenoxialkyl)imidazolderivat FI70888C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13
GB7848367 1978-12-13

Publications (3)

Publication Number Publication Date
FI793868A FI793868A (fi) 1980-06-14
FI70888B FI70888B (fi) 1986-07-18
FI70888C true FI70888C (fi) 1986-10-27

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793868A FI70888C (fi) 1978-12-13 1979-12-11 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara n-(fenoxialkyl)imidazolderivat

Country Status (34)

Country Link
US (2) US4602016A (ru)
JP (1) JPS585197B2 (ru)
KR (1) KR830001243B1 (ru)
AR (1) AR227637A1 (ru)
AT (1) AT373879B (ru)
AU (1) AU517892B2 (ru)
BE (1) BE880584A (ru)
CA (1) CA1108137A (ru)
CH (1) CH644597A5 (ru)
CS (1) CS216517B2 (ru)
DD (1) DD147943A5 (ru)
DE (1) DE2950019A1 (ru)
DK (1) DK471479A (ru)
EG (1) EG14227A (ru)
ES (1) ES8101556A1 (ru)
FI (1) FI70888C (ru)
FR (1) FR2444031A1 (ru)
GB (1) GB2038821B (ru)
GR (1) GR73003B (ru)
HU (1) HU183016B (ru)
IE (1) IE49318B1 (ru)
IL (1) IL58917A (ru)
IT (1) IT1194900B (ru)
LU (1) LU81985A1 (ru)
NL (1) NL177749C (ru)
NO (1) NO153135C (ru)
NZ (1) NZ192360A (ru)
PH (1) PH15056A (ru)
PL (1) PL134005B1 (ru)
PT (1) PT70571A (ru)
SE (1) SE444937B (ru)
SU (1) SU878195A3 (ru)
YU (1) YU301879A (ru)
ZA (1) ZA796708B (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−(1−イミダゾリル)アルキルオキシ(またはチオ)ベンゼン誘導体
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES539074A0 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
US4894385A (en) * 1985-01-16 1990-01-16 Sankyo Company Limited Imidazole derivatives as inhibitors of TXA2 synthesis
NO166644C (no) 1986-01-28 1991-08-21 Sankyo Co Analogifremgangsmaate til fremstilling av tianaftenderivater.
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
AU2890899A (en) * 1998-03-13 1999-09-27 Pozen, Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
JP2005533830A (ja) * 2002-07-09 2005-11-10 ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ トロンボキサンa2受容体アンタゴニストおよびcox−2阻害剤の薬剤の組み合わせ
CA2534316A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
EP2543368A1 (en) 2007-12-11 2013-01-09 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
EA026393B1 (ru) * 2012-05-22 2017-04-28 Дженентек, Инк. N-замещенные бензамиды и их применение в лечении боли
RU2015119640A (ru) 2012-10-26 2016-12-20 Мерк Шарп И Доум Корп. Соединения n-замещенного индазол-сульфонамида с избирательной активностью в потенциал-зависимых натриевых каналах
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
WO2023240378A1 (zh) * 2022-06-13 2023-12-21 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
JPS585197B2 (ja) 1983-01-29
AU517892B2 (en) 1981-09-03
SE7910204L (sv) 1980-06-14
ATA783379A (de) 1983-07-15
CS216517B2 (en) 1982-11-26
CH644597A5 (de) 1984-08-15
AU5372579A (en) 1980-06-19
IL58917A0 (en) 1980-03-31
NZ192360A (en) 1982-02-23
KR830001243B1 (ko) 1983-06-27
PL134005B1 (en) 1985-07-31
CA1108137A (en) 1981-09-01
ES486782A0 (es) 1980-12-16
DK471479A (da) 1980-06-14
DE2950019A1 (de) 1980-07-10
IT1194900B (it) 1988-09-28
LU81985A1 (fr) 1980-04-22
AT373879B (de) 1984-02-27
AR227637A1 (es) 1982-11-30
HU183016B (en) 1984-04-28
NO153135C (no) 1986-01-22
YU301879A (en) 1983-01-21
DD147943A5 (de) 1981-04-29
FR2444031A1 (fr) 1980-07-11
IT7941669A0 (it) 1979-12-11
SE444937B (sv) 1986-05-20
GB2038821A (en) 1980-07-30
IE792403L (en) 1980-06-13
FI793868A (fi) 1980-06-14
EG14227A (en) 1983-12-31
JPS5585572A (en) 1980-06-27
NL7908899A (nl) 1980-06-17
NL177749B (nl) 1985-06-17
KR830001242A (ko) 1983-04-29
GR73003B (ru) 1984-01-24
NO153135B (no) 1985-10-14
NL177749C (nl) 1985-11-18
PL220351A1 (ru) 1980-12-01
ZA796708B (en) 1981-08-26
US4636500A (en) 1987-01-13
US4602016A (en) 1986-07-22
BE880584A (fr) 1980-06-12
IE49318B1 (en) 1985-09-18
PT70571A (en) 1980-01-01
FR2444031B1 (ru) 1983-06-10
GB2038821B (en) 1982-12-08
PH15056A (en) 1982-06-03
IL58917A (en) 1984-03-30
SU878195A3 (ru) 1981-10-30
NO794069L (no) 1980-06-16
ES8101556A1 (es) 1980-12-16
FI70888B (fi) 1986-07-18

Similar Documents

Publication Publication Date Title
FI70888C (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara n-(fenoxialkyl)imidazolderivat
FI66860C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-1-imidazolylalkyl)-indolderivat
US4448781A (en) N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme
IE53739B1 (en) Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4339583A (en) (Imidazolylmethyl)pyridine compounds as thromboxane synthetase inhibitors
EP0054417B1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
EP0035863B1 (en) Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
GB2041363A (en) N-Benzyl-imidazoles
US4259345A (en) 2-(Imidazol-1-ylmethyl)pyrroles
US4230714A (en) Imidazole therapeutic agents
EP0069513A2 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
GB2065121A (en) Isoquinoline Derivatives
GB2118552A (en) Thromboxane synthetase inhibitors
GB2101115A (en) Thromboxane synthetase inhibitors
GB2102795A (en) Indole derivatives
US4925855A (en) Imidazole derivatives and antimycotics containing them
JP5395905B2 (ja) 抗炎症化合物
GB2068950A (en) Pyridine Derivatives

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER CORPORATION